PHVS
Pharvaris N.V.
NASDAQ · Healthcare · Biotechnology · NL
$35.25
−1.15%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-57.0%
Return on equity
-52.2%
Return on assets
-60.7%
Return on invested capital
0.00x
Asset turnover
-$181.3M
Cash from operations
$5.27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026